Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|April 13, 2007
Safety issues and prospects for future generations of PPAR modulatorsAnne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.
Diabetes & Vascular Disease Research|September 13, 2014
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effectsRémy Hanf, Lesley J Millatt, Bertrand Cariou, et al.
Diabetes Care|May 30, 2013
Dual peroxisome proliferator-activated receptor α/δ agonist GFT505 improves hepatic and peripheral insulin sensitivity in abdominally obese subjectsBertrand Cariou, Rémy Hanf, Stéphanie Lambert-Porcheron, et al.
Frontiers in Veterinary Science|December 8, 2025
Cathepsin K inhibition by VBX1000 alleviates canine periodontitisJerzy Gawor, Daria Ziemann Gawor, Isabelle Druet, et al.
European Heart Journal|July 31, 2012
Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein productionSophie Colin, Olivier Briand, Véronique Touche, et al.
Hepatology (Baltimore, Md.)|May 25, 2013
Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisBart Staels, Anne Rubenstrunk, Benoit Noel, et al.
Frontiers in Veterinary Science|June 24, 2026
Piclidenoson, an A3 adenosine receptor agonist, demonstrates clinical benefit in canine osteoarthritis: a pilot studyRémy Hanf, Avital Bareket-Samish, Pierre Moulin, et al.
Metabolism: Clinical and Experimental|December 1, 2019
Bile acids associate with glucose metabolism, but do not predict conversion from impaired fasting glucose to diabetesOscar Chávez-Talavera, Matthieu Wargny, Matthieu Pichelin, et al.
The Lancet. Gastroenterology & Hepatology|August 9, 2020
A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation studyStephen A Harrison, Vlad Ratziu, Jérôme Boursier, et al.
Pageof 1